Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
about
The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migrationIRF7: activation, regulation, modification and functionLigand modulation of the Epstein-Barr virus-induced seven-transmembrane receptor EBI2: identification of a potent and efficacious inverse agonistOncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expressionInterferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesMicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathwaysB-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 elementAnalysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cellsEpstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.Transcriptomic Analysis of Persistent Infection with Foot-and-Mouth Disease Virus in Cattle Suggests Impairment of Apoptosis and Cell-Mediated Immunity in the NasopharynxEpstein-Barr virus latent genesProlonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expressionEBI2 mediates B cell segregation between the outer and centre follicleMolecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activityLupeol is one of active components in the extract of Chrysanthemum indicum Linne that inhibits LMP1-induced NF-κB activationGenetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activationc-Rel deficiency increases caspase-4 expression and leads to ER stress and necrosis in EBV-transformed cellsEBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors.Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo.Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis.Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells.NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1Virus and cell RNAs expressed during Epstein-Barr virus replicationRNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines.IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.Functional characterization of Trip10 in cancer cell growth and survival.Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathwaysCellular target genes of Epstein-Barr virus nuclear antigen 2.RNA CoMPASS: a dual approach for pathogen and host transcriptome analysis of RNA-seq datasetsLMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaBNF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis.EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues.
P2860
Q21146664-89D19D11-754C-4638-84B5-401A4EFAA0C6Q24299740-3DCC9504-4C74-4C63-9429-FBF3AF8CFD5DQ24306565-4C76F195-82BF-497C-8926-ADF44CF74153Q24625246-6103C429-3481-4854-BEDC-7704A07809D7Q24646670-8AD5171E-E396-4B34-964D-AC51DC4F7BF5Q24650451-721AA45F-CC4F-42F9-B76B-D0DADAC7C9EDQ24658165-759F93FC-59E4-444E-A143-C199EB6DC5C4Q24675683-4725ACDC-A6EC-45D0-98E0-B18648560780Q24816875-DCBABB5F-DA05-4B5D-B321-05ED7A323F7AQ27322442-90341245-A6B4-4165-88ED-8880D6435F87Q28082701-776EEBD7-3165-4CF7-ACB7-B175710EFFA8Q28193489-990FB112-65C6-437B-935E-4464A25B8C94Q28251850-A1643ABE-F3F3-444A-9920-2DA0FA9FC9E9Q28302291-25B82FD7-00EC-49C0-9F19-D59DEF5314A6Q28535439-745A78A9-620F-4EBC-B88C-672E2FD9F43EQ28731826-946BF0CA-3E96-4E56-9298-4C2782C7AD75Q28744344-82AB2B73-AAD3-447C-8AB7-611657D45120Q30837949-3B99528D-7419-49F5-8415-A29796C748C6Q33227187-AC614872-A225-4E1C-8743-51C63BE0365BQ33724152-474D556A-76EC-4B9A-99C1-7C3507B027B7Q33748089-A856E2F7-F302-4AEE-979F-21765573FB5DQ33877497-1005513E-EF2A-46A0-A992-3F4E4C2DCBECQ34143653-A984FB5F-D695-43A3-BBCE-EF3264FC8CFAQ34152172-D0AD35C7-594D-41D5-9E1B-6753EACAE209Q34241279-B823A17B-FC86-42DF-9919-ADBCE980F90FQ34253049-83340DE6-F216-4A58-997B-ADCBC677020DQ34352790-7170524E-721A-48C6-81FC-6FE22DEA34BAQ34384112-64F8AA16-5E9E-4A0D-B346-803A25A1FE1DQ34405076-07DF0AA2-CE4F-4537-AA56-5A8E7082FC72Q34434702-5FD5A7ED-63F5-4A48-A2A3-81796F11BC4CQ34478739-B06B453A-7851-43BA-A66F-5B0ED53F8323Q34479733-E7CE6E74-30D7-409D-AAAD-DA2311170363Q34600622-C90962FB-B5C7-42A9-8C2D-76182C9CEB6CQ34627655-BB6EAAF6-8A5A-453C-A3E0-F3C1054519B6Q34721581-95D1E41C-5B00-4C57-8C64-28782C6A4CD0Q35101342-3A333458-E385-4C2E-B78E-DCBD4A4E5DC8Q35107335-D1820658-F295-44A5-9E02-234D89AA7D8AQ35139273-CD1975A7-0620-4D5F-841C-08DDE4CE0B91Q35193057-733E96A2-FE7A-45CD-9D46-451BD0DFFCF2Q35204626-E44158BF-133E-4696-A1B9-721C277789E0
P2860
Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of NF-kappa B in cell sur ...... us latency III-infected cells.
@en
Role of NF-kappa B in cell sur ...... us latency III-infected cells.
@nl
type
label
Role of NF-kappa B in cell sur ...... us latency III-infected cells.
@en
Role of NF-kappa B in cell sur ...... us latency III-infected cells.
@nl
prefLabel
Role of NF-kappa B in cell sur ...... us latency III-infected cells.
@en
Role of NF-kappa B in cell sur ...... us latency III-infected cells.
@nl
P2093
P2860
P1433
P1476
Role of NF-kappa B in cell sur ...... us latency III-infected cells.
@en
P2093
Andreas Rosenwald
Ellen D Cahir-McFarland
Jena M Giltnane
Kara Carter
Louis M Staudt
Sarah E Henrickson
P2860
P304
P356
10.1128/JVI.78.8.4108-4119.2004
P407
P577
2004-04-01T00:00:00Z